News

McLaren High Performance Network, LLC received a perfect MIPS score of 100 out of 100 for performance year 2018. This score was calculated based on performance in Quality, Advancing Care Information, and Improvement Activities. CMS categorizes any score greater than 70 as exceptional performance. Based on this performance, eligible providers in the McLaren High Performance Network will receive a 1.68% positive payment adjustment in Calendar Year 2020. The 2020 MIPS payment adjustments vary between -5% a...

MPP is pleased to announce a new Medicare Advantage HMO agreement has been signed with Reliance ACO. Our includes McLaren hospitals and active MPP providers in the following regions: McLaren Flint McLaren Lapeer McLaren Macomb McLaren Oakland McLaren Port Huron Karmanos Cancer Center The new contract with Reliance is effective January 1, 2020. Pursuant to your Master Membership Agreement with MPP, active members will be included in the provider network unless written notification of your intent to opt o...

MPP is pleased to announce a new Gain Sharing Agreement has been signed with Humana. We have expanded our existing MPP agreement for Medicare Advantage to include all regions. Our current agreement now includes all McLaren hospitals and active MPP providers in the following regions: McLaren Bay and Bay Special Care (LTACH) McLaren Caro McLaren Central McLaren Flint McLaren Greater Lansing McLaren Lapeer McLaren Macomb McLaren Oakland McLaren Northern McLaren Port Huron McLaren Thumb Region Karmanos Canc...

McLaren Physician Partners (MPP) is pleased to announce the release of the MPP Clinical Integration Payment 2 of 2 for 2018. This payment is based on physician performance on quality measures and value-based payments received from August 2018-January 2019. The total distribution amount is $3,167,210. As we transition to value-based payments, our top performing physicians have received the following in the 2018 Payment 2: Summary of MPP 2018 Payment 2 Max Min Median PCP $33,187 $100 $4,942 SPC $1,191 $65...

MPP received a request for help from one of our members in delivering the message of why it is important to use the McLaren network. Patients are asking why it is beneficial for them to stay within our network. In response, we have created a patient-facing flyer that addresses reasons why patients should stay within the McLaren network. Excerpts from the flyer include the following: Getting your care from a McLaren provider helps me (your provider) provide you with the best quality care possible. One of...

Clinical Integration Payment 1 for 2018 McLaren Physician Partners (MPP) is pleased to announce the release of the MPP Clinical Integration Payment 1 of 2 for 2018. This payment is based on physician performance on quality measures and value-based payments received from February – July 2018. The total distribution amount is $4,029,762. As we transition to value-based payments our top performing physicians have received the following in the 2018 calendar year: Summary of MPP CY 2018 Payments   Max M...

Adults 40–75 years of age with diabetes, who do or do not have clinical atherosclerotic cardiovascular disease (ASCVD), should be started on a statin for primary and secondary prevention of ASCVD regardless of lipid status. Medications One of the following medications must have been dispensed. Note: The active ingredients are limited to oral formulations only. Drug Category Medications Statin medications * Lovastatin * Fluvastatin * Pravastatin * Simvastatin * Rosuvastatin * Atorvastatin * Pitavastatin ...

Produced by the National Kidney Foundation, Inc. All rights reserved. Renal dysfunction is a potentially pivotal development in diabetes, and microalbuminuria is generally the first clinical sign of renal complication. Screening for albuminuria may be the most effective way to identify patients early who are at increased risk for renal events. Produced by the National Kidney Foundation, Inc. All rights reserved. Produced by the National Kidney Foundation, Inc. All rights reserved. If you have any questi...

Pap tests in women aged 21-29 and 30 – 65 years of age In average risk women, annual cervical cytology screening has been shown to offer no advantage over screening performed at 3-year intervals, without HPV co-testing, for age 21-29 or 5-year intervals, with HPV co-testing, for age 30-65. However, a well-woman visit should occur annually to discuss prevention practices, recognizing risk factors for disease, identifying medical problems, and establishing the clinician–patient relationship. Women who hav...

MAPS This facility utilizes the Michigan Automated Prescription System In partnership with the state of Michigan to assist in the prevention of prescription drug abuse, diversion, overprescribing, and overdispensing of controlled substances, and to ensure the health and safety of our community. michigan.gov/mimapsinfo For members 18 years and older, the rate per 1,000 receiving prescription opioids at a high dosage for at least 15 days during the measurement year (average morphine equivalent dose [MED] ...